Cargando…

Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?

The COVID-19 pandemic has engulfed the entire world and has claimed more than 3 million lives worldwide. This viral disease is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and mainly characterized by fever, dry cough, fatigue, anosmia, anorexia, and dyspnea. The severity of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinha, Saptarshi, Kundu, Chanakya Nath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302962/ https://www.ncbi.nlm.nih.gov/pubmed/34302557 http://dx.doi.org/10.1007/s12032-021-01553-3

Ejemplares similares

Aging, Social Distancing, and COVID-19 Risk: Who is more Vulnerable and Why?
por: Faraji, Jamshid, et al.
Publicado: (2021)

Why are pregnant women susceptible to COVID-19? An immunological viewpoint
por: Liu, Hong, et al.
Publicado: (2020)

Why large cities are more vulnerable to the COVID-19 pandemic
por: Lai, Shih-Kung, et al.
Publicado: (2022)

Immunotherapy in COVID-19: why, who, and when?
por: Sinha, Pratik, et al.
Publicado: (2021)

Why the elderly appear to be more severely affected by COVID‐19: The potential role of immunosenescence and CMV
por: Kadambari, Seilesh, et al.
Publicado: (2020)

Why Is COVID-19 More Concentrated in Countries with High Economic Status?
por: Bayati, Mohsen
Publicado: (2021)

Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women?
por: Bwire, George M.
Publicado: (2020)

Why Was There More Household Stock Market Participation During the COVID-19 Pandemic?
por: Zheng, Wenyuan, et al.
Publicado: (2022)

Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage
por: Siddharth, Sumit, et al.
Publicado: (2017)

Why the COVID-19 Is Not Significantly Reduced in Iran?
por: Asgharzadeh, Mohammad, et al.
Publicado: (2021)

Why do children seem to be more protected against COVID-19? A hypothesis
por: Sposato, Bruno, et al.
Publicado: (2020)

Treatment of Gastric Cancer Patients During COVID-19 Pandemic: The West is More Vulnerable
por: Polkowski, Wojciech Piotr, et al.
Publicado: (2020)

The Paradox of COVID-19 in Sub-Saharan Africa: Why it is More Unethical Not to Investigate Low Dose Radiotherapy for COVID-19
por: Mortazavi, Seyed Alireza, et al.
Publicado: (2022)

Why pay more for robot in esophageal cancer surgery?
por: Rebecchi, Fabrizio, et al.
Publicado: (2022)

COVID-19, Scarce Resources and Priority Ethics: Why Should Maximizers Be More Conservative?
por: Afroogh, S., et al.
Publicado: (2021)

Why the complications of COVID-19 patients differ in elderly and young cancer patients
por: Bravaccini, Sara, et al.
Publicado: (2022)

Why the world economy needs, but will not get, more globalization in the post-COVID-19 decade
por: Ciravegna, Luciano, et al.
Publicado: (2021)

Computed tomography chest in COVID-19: When & why?
por: Garg, Mandeep, et al.
Publicado: (2021)

Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami
por: Sharbatdar, Yasamin, et al.
Publicado: (2023)

Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19
por: Shafiee, Sepehr, et al.
Publicado: (2021)

COVID-19-associated mucormycosis in India: Why such an outbreak?
por: Pasquier, Gregoire
Publicado: (2023)

Mass Testing and Proactiveness Affect Epidemic Spreading
por: Sinha, Saptarshi, et al.
Publicado: (2021)

mRNA vaccines for COVID-19: what, why and how
por: Park, Jung Woo, et al.
Publicado: (2021)

Why does COVID-19 disproportionately affect older people?
por: Mueller, Amber L., et al.
Publicado: (2020)

Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers
por: Başcı, Semih, et al.
Publicado: (2021)

More light on cancer and COVID-19 reciprocal interaction
por: Brest, Patrick, et al.
Publicado: (2021)

COVID-19 Vaccination and Cancer, the Need for more Data
por: Javadinia, Seyed Alireza, et al.
Publicado: (2021)

Placental Galectins in Cancer: Why We Should Pay More Attention
por: Fuselier, Camille, et al.
Publicado: (2023)

Why skyscrapers after Covid-19?
por: Smith, Richard G.
Publicado: (2021)

Metformin in COVID-19: Is There a Role Beyond Glycemic Control?
por: Nagendra, Lakshmi, et al.
Publicado: (2023)

Nanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1
por: Nayak, Anmada, et al.
Publicado: (2016)

Why will it never be known if convalescent plasma is effective for COVID-19
por: Rojas, Manuel, et al.
Publicado: (2020)

Are COVID-19 susceptibility genes related to lung cancer?
por: Qiu, Shizheng, et al.
Publicado: (2021)

“One more time”: why replicating some syntheses of evidence relevant to COVID-19 makes sense
por: Page, Matthew J., et al.
Publicado: (2020)

Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade
por: Das, Sarita, et al.
Publicado: (2016)

Ethical communication to patient & society: a critical responsibility in COVID-19 pandemic
por: Chatterjee, Saptarshi
Publicado: (2020)

Alu retrotransposons and COVID-19 susceptibility and morbidity
por: Li, Manci, et al.
Publicado: (2021)

Diabetes and susceptibility to infections: Implication for COVID‐19
por: van Niekerk, Gustav, et al.
Publicado: (2021)

The COVID-19 Vaccine: Why the Hesitancy?
por: Grossman, Valerie Aarne
Publicado: (2021)

Why is COVID-19 rising in summer?
por: Kulkarni, Raghavendra D.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_urq0eobaa457fa0vf6skrfmrv6